Evidence map›Paper›PMID 41625835›Full record

ArticleCureus2025

Heparin-Induced Thrombocytopenia in a Patient With Postoperative Pulmonary Embolism: D-dimer Re-elevation and Progressive Pulmonary Artery Thrombosis.

Satoshi Kurisu, Hitoshi Fujiwara, Yutaka Tanaka

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Satoshi KurisuDepartment of Cardiology, National Hospital Organization Hiroshima Nishi Medical Center, Otake, JPN.
Hitoshi FujiwaraDepartment of Cardiology, National Hospital Organization Hiroshima Nishi Medical Center, Otake, JPN.
Yutaka TanakaDepartment of Orthopedics, National Hospital Organization Hiroshima Nishi Medical Center, Otake, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heparin-induced thrombocytopenia (HIT) is a rare but serious immune-mediated complication of heparin therapy, characterized by thrombocytopenia and paradoxical thrombosis. We report a case of HIT in an 83-year-old woman who developed postoperative pulmonary embolism (PE). Continuous unfractionated heparin was initiated, leading to initial improvement. However, seven days after PE and heparin initiation, thrombocytopenia and D-dimer re-elevation occurred without new symptoms. Her 4Ts score was 7, prompting a switch from heparin to argatroban. HIT antibodies were subsequently confirmed, and computed tomography (CT) revealed a new thrombus in the main pulmonary artery. Argatroban was later replaced with edoxaban after platelet recovery. Both thrombocytopenia and D-dimer levels gradually improved, and the patient was discharged 30 days after PE onset. Outpatient follow-up CT confirmed complete thrombus resolution. Clinicians should maintain a high index of suspicion for HIT in heparin-treated patients presenting with thrombocytopenia, with supportive laboratory findings such as unexpected D-dimer elevation, even in the absence of new or worsening symptoms. Early recognition and prompt management are essential to improve outcomes and prevent severe complications or death.

Indexed as

4ts scoreanticoagulant therapycomputed tomography pulmonary angiographythromboembolic diseasevenous thromboembolism (vte)

Identifiers

PMID41625835
PMCPMC12854933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.